Mikael Bergelin

Mikael Bergelin serves as a Research Leader at the Faculty of Science and Engineering, Åbo Akademi University, with significant affiliation to the Turku PET Centre. His interdisciplinary research bridges biomedical engineering and materials science, focusing on developing innovative measurement systems with clinical and industrial applications.

Dr. Bergelin's primary research interests include:

• Bioimpedance technology for medical applications, particularly wound monitoring and healing assessment
• Development of sensor arrays for long-term clinical monitoring
• Corrosion science, with emphasis on material degradation mechanisms
• Radiochemistry applications for PET tracer production

Analysis of his publication record reveals a strong trajectory in biomedical sensor development, with increasing focus on clinical applications of bioimpedance technology since 2015. His work demonstrates successful interdisciplinary collaboration between medical researchers and engineers, resulting in both scientific publications and practical applications like patented corrosion detection methods. Recent publications show continued innovation in non-invasive wound monitoring techniques with potential for significant clinical impact, as evidenced by substantial citation counts (42 citations for his 2019 Sensors article).

Dr. Bergelin has contributed to multiple research collaborations across institutions, resulting in 39 documented research outputs including 28 articles, 8 conference proceedings, 2 book chapters, and 1 granted patent. His work has garnered attention in both academic circles and practical applications, with Mendeley showing 39 readers for his publications.

As a Research Leader at the Turku PET Centre, Dr. Bergelin is involved in advanced medical imaging research, particularly related to positron emission tomography. His team focuses on developing novel measurement systems that bridge engineering principles with clinical applications, with recent work extending to radiochemistry for [11C]CH4 production as evidenced by his 2025 publication.